CRP and cancer: The present literature shows that CRP has been largely studied in cancer, and in a large representative cohort of consecutive solid tumor adults, the risk of death was clinically and statistically significantly greater with a high mCRP, and this was independent of some other studied parameters; when mCRP values > 10 mg/L were subcategorized, a higher mCRP was always worse, and even among cases with normal values, statistically and clinically significant shorter survival was seen at >5 mg/L [775].